Effects of individual micronutrients on blood pressure in patients with type 2 diabetes: A systematic review and meta-analysis of randomized clinical trials

Scientific Reports

Volumn 7, Issue , 2017, Pages

  De Paula, Tatiana P ^a   Kramer, Caroline K ^b   Viana, Luciana V ^a   Azevedo, Mirela J ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRACE ELEMENT; VITAMIN;

AGED; BLOOD PRESSURE; DIETARY SUPPLEMENT; DRUG EFFECT; FEMALE; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGED; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MICRONUTRIENTS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRACE ELEMENTS; VITAMINS;

EID: 85009471680     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep40751     Document Type: Article

References (38)

1. Stratton, I. M. et al. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: A prospective observational study (UKPDS 75). Diabetologia 49, 1761-1769 (2006).
2. American Diabetes Association Diabetes Statistics. Internet: http://www.diabetes.org/diabetes-basics/diabetes-statistics/loc= DropDownDB-stats 2011; Date of acess 17/01/2016 (2016).
3. Pinto, L. C. et al. Inadequate blood pressure control in patients with type 2 diabetes mellitus. Arq Bras Cardiol 94, 651-655 (2010).
4. James, P. A. et al. Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5), 507-520 (2014).
5. Heerspink, H. J. L. et al. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int 82, 330-337 (2012).
6. Sacks, F. M. & Campos, H. Dietary therapy in hypertension. N Engl J Med 362, 2102-2112 (2010).
7. Appel, L. J. et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group. N Engl J Med 336, 1117-1124 (1997).
8. Sacks, F. M. et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 344, 3-10 (2001).
9. Standards of medical care in diabetes DiabetesCare 39 (Suppl 1), S1-S110 (2016).
10. National Institute for Clinical Excellence. CG127 hypertension clinical management of primary hypertension in adults. NICE Guideline (2011).
11. Mancia, G. et al. ESH/ESC Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal 34, 2159-2219 (2013).
12. Paula, T. P. et al. The role of dietary approaches to stop hypertension (DASH) diet food groups in blood pressure in type 2 diabetes. Br J Nutr 108, 155-162 (2012).
13. Azadbakht, L. et al. Effects of the dietary approaches to stop hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients. Diabetes Care 34, 55-57 (2011).
14. Paula, T. P. et al. Effects of the DASH Diet and Walking on Blood Pressure in Patients With Type 2 Diabetes and Uncontrolled Hypertension: A Randomized Controlled Trial. J Clin Hypertens 17, 895-901 (2015).
15. Dodson, P. M. et al. Sodium restriction and blood pressure in hypertensive type II diabetics: randomized blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. BMJ 298, 227-30 (1989).
16. Guerrero-Romero, M. & Rodrigues Moran, M. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: A randomized, doubleblind, placebo-controlled clinical trial. J Hum Hypertens 23, 245-251 (2009).
17. Darko, D. et al. Lack of effect of oral Vitamin C on blood pressure, oxidative stress and endothelial function in type II diabetes. ClinSci (lond) 103, 339-344 (2002).
18. Mullan, B., Young, I. S., Fee, H. & Mccance, D. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 40, 804-809 (2002).
19. Witham, M. D. et al. The effect of different doses of Vitamin D3 on markers of vascular health in patients with type 2 diabetes: A randomised controlled Trial. Diabetologia 53, 2112-2119 (2010).
20. Sugden, J. A. et al. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low Vitamin D levels. Diabet Med 25, 320-325 (2008).
21. Shab-Bidar, S. et al. Regular consumption of Vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: A randomized double-blind clinical trial. BMC Medicine 9, 125-135 (2009).
22. Nasri, H. et al. Impact of oral Vitamin D (cholecalciferol) replacement therapy on blood pressure in type 2 diabetes patients; a randomized, double-blind, placebo controlled clinical trial. J Nephropathol 3, 29-33 (2014).
23. Nikooyeh, B., Neyestani, T. R., Farvid, M. et al. Daily consumption of Vitamin Dor Vitamin D+ calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: A randomized clinical trial. Am J Clin Nutr 93, 764-71 (2011).
24. Breslavsky, A., Frand, J., Matas, Z. et al. Effect of high doses of Vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr 32, 970-975 (2013).
25. Al-Zahrani et al. A 3-month oral Vitamin D supplementation marginally improves diastolic blood pressure in Saudi patients with type 2 diabetes mellitus. Int J Clin Exp Med 7, 5421-5428 (2014).
26. Higgins, J. P. T. & Green, S. (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. Available from http://http://handbook.cochrane.org/Date of access: 29/09/2016 (2011).
27. Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62, 1-34 (2009).
28. Higgins, J. P. et al. Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343, d5928 (2011).
29. Balshem, H. et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64, 401-406 (2011).
30. Follmann, D. et al. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 45, 769-773 (1992).
31. Juraschek, S. P. et al. Effects of Vitamin C supplementation on blood pressure: A meta-analysis of randomized controlled trials. Am J Clin Nutr 95, 1079-1088 (2012).
32. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Washington (DC): National Academies Press (US); ISBN-10: 0-309-06350-7ISBN-10: 0-309-06403-1 (1997).
33. Witham, M. D., Adnan Nadir, M. & Struthers, A. D. Effect of Vitamin D on blood pressure: A systematic review and meta-analysis. J Hypertension 27, 1948-1954 (2009).
34. Beveridge, L. A. et al. Effect of Vitamin D Supplementation on Blood Pressure A Systematic Review and Meta-analysis Incorporating Individual Patient Data. JAMA 175(5), 745-754 (2015).
35. Lee, K. J. & Lee, Y. J. Effects of Vitamin D on blood pressure in patients with type 2 diabetes mellitus. Int J Clin Pharm and Therap 4, 233-242 (2016).
36. Holick, M. F., Bischoff-Ferrari, H. A., Gordon, C. M. et al. Evaluation, treatment, and prevention of Vitamin D deficiency: An Endocrine Society clinical practice Guideline. J Clin Endocrin Metab 96, 1911-1930 (2011).
37. McGreevy, C. & Williams, D. New insights about Vitamin D and cardiovascular disease. Ann Intern Med 155, 820-882 (2011).
38. Grossman, H. Ambulatory blood pressure monitoring in the diagnosis and management of hypertension. Diabetes Care 36(suppl 2), 307-331 (2013).